Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREST: Preoperative Sorafenib Therapy in Renal Cell Carcinoma
2008-002667-13Phase 2Terminated
- Sponsor
- Heidelberg University Hospital
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of sorafenib in renal cell carcinoma (RCC) (2 arms), sponsored by Heidelberg University Hospital. Primary endpoints: Tumor gene and protein expression profile comparison, Early radiologic susceptibility assessment and 1 more. Started Jul 2008; status: terminated.
02
Drugs
sorafenib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on 2008-002667-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002667-13.